Bridging platforms for enhanced & harmonized bioprocess data collaboration
Learn about the tools available to facilitate and harmonize your bioprocess data collaboration.
In the highly specialized field of bioprocess development, designing and optimizing complex processes with maximum efficiency is crucial. Bioprocess engineering demands seamless convergence between research and development, as well as scalable production. However, manual data handling, for example in cell culture, vector production and downstream processing, is often tedious, prone to errors and can significantly impede the research processes. Automation of these processes saves valuable time and enhances data accuracy and reproducibility — key factors in regulatory compliance and therapeutic development. This is where technologies like the Eppendorf BioNsight® cloud solution truly excel, providing easy access to clean, formatted data that is ready for analysis. In this webinar, explore the tools available to facilitate your bioprocess data collaboration.
What will you learn?
- Learn about efficient bioprocess monitoring from wherever you are.
- Explore tools for bioprocess automation, in silico simulations and advanced analytics.
- Gain insight into the benefits of a platform bridging these tools for efficient bioprocess data management.
Who this may interest?
- Bioprocess engineers
- Lab technicians
- Group leaders
- Researchers
Speaker
Benjamin Wolters
Research Scientist
Eppendorf Bioprocess Center (Jülich, Germany)
Benjamin Wolters is a research scientist at the Eppendorf Bioprocess Center where he is responsible for the validation of current products and support of new product development, as well as evaluating and assessing novel technologies for possible integration into the bioprocess product portfolio. Benjamin holds a Master’s degree in biotechnolgy and obtained his PhD in biology from the University of Bonn (Germany) after 3 years of research at the Helmholtz Research Center (Jülich, Germany). Before joining the company, he worked with induced pluripotent stem cells and their derivatives for several well-known companies in the industry.
This webinar was recorded on 20 May 2025.
In association with
